We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.71B
1-Year Est. Return 106.31%
This Fund
S&P 500
This Quarter Est. Return
+6.36%
1 Year Est. Return
+106.31%
3 Year Est. Return
+266.76%
5 Year Est. Return
+310.53%
10 Year Est. Return
+1,580.35%
AUM
$4.56B
AUM Growth
-$316M
Cap. Flow
-$742M
Cap. Flow %
-16.27%
Top 10 Hldgs %
15.49%
Holding
2,634
New
531
Increased
353
Reduced
471
Closed
900

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$26.9M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$24.7M
3
AMZN icon
Amazon
AMZN
+$22.4M
4
INDV icon
Indivior Pharmaceuticals
INDV
+$21.7M
5
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$18M

Top Sells

Rank Stock Value
1
CVII
Churchill Capital Corp VII Class A Common Stock
CVII
+$23.1M
2
WMT icon
Walmart Inc
WMT
+$17.7M
3
BURL icon
Burlington
BURL
+$12.7M
4
ALCE
Alternus Clean Energy Inc
ALCE
+$12.1M
5
GILD icon
Gilead Sciences
GILD
+$11.7M

Sector Composition

Rank Sector Weight
1 Healthcare 9.99%
2 Technology 9.63%
3 Financials 7.8%
4 Industrials 6.22%
5 Consumer Discretionary 5.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CPTNW
1651
DELISTED
Cepton, Inc. Warrant
CPTNW
$11K ﹤0.01%
22,591
– –
AMRS
1652
CALL
DELISTED
Amyris Inc.
AMRS
$10.5K ﹤0.01%
10,200
-63,700
-86% -$59.3K
BRLIR
1653
DELISTED
Brilliant Acquisition Corporation Rights
BRLIR
$10.4K ﹤0.01%
74,155
– –
VHC icon
1654
VirnetX Holding Corp
VHC
$54.4M
$9.36K ﹤0.01%
1,006
-244
-20% -$3K
BLEUR
1655
DELISTED
bleuacacia ltd Rights
BLEUR
$4.55K ﹤0.01%
+52,873
New +$3K
NAVB
1656
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$3.68K ﹤0.01%
+40,000
New +$6.38K
VBIO
1657
Valion Bio
VBIO
$1.29M
$3.62K ﹤0.01%
20
+2
+11% +$429
BREZR
1658
DELISTED
Breeze Holdings Acquisition Corp. Right
BREZR
$3.31K ﹤0.01%
32,911
– –
KYCHR
1659
DELISTED
Keyarch Acquisition Corporation Rights
KYCHR
$2.85K ﹤0.01%
20,000
– –
GFGDR
1660
DELISTED
The Growth for Good Acquisition Corporation Right
GFGDR
$2.5K ﹤0.01%
17,838
– –
AAPL icon
1661
CALL
Apple
AAPL
$4.54T
– –
-61,000
Closed -$10.1M
AAT
1662
American Assets Trust
AAT
$1.45B
– –
-21,349
Closed -$397K
ABLLW
1663
DELISTED
Abacus Life Warrant
ABLLW
– –
-60,463
Closed -$620K
ABR icon
1664
Arbor Realty Trust
ABR
$964M
– –
-24,387
Closed -$280K
ACAD icon
1665
Acadia Pharmaceuticals
ACAD
$4.43B
– –
-12,856
Closed -$242K
ACDC icon
1666
ProFrac Holding
ACDC
$731M
– –
-17,687
Closed -$224K
ACHC icon
1667
Acadia Healthcare
ACHC
$2.76B
– –
-53,859
Closed -$3.89M
ACRE
1668
Ares Commercial Real Estate
ACRE
$236M
– –
-10,957
Closed -$99.6K
ACRS icon
1669
CALL
Aclaris Therapeutics
ACRS
$726M
– –
-262,400
Closed -$2.12M
ACTG icon
1670
Acacia Research
ACTG
$428M
– –
-18,000
Closed -$69.5K
ACTG icon
1671
PUT
Acacia Research
ACTG
$428M
– –
-18,000
Closed -$69.5K
ACVA icon
1672
ACV Auctions
ACVA
$1.31B
– –
-51,400
Closed -$664K
ADC icon
1673
Agree Realty
ADC
$9.34B
– –
-62,076
Closed -$4.26M
ADEA icon
1674
Adeia
ADEA
$2.94B
– –
-59,730
Closed -$529K
ADM icon
1675
Archer Daniels Midland
ADM
$38.2B
– –
-5,142
Closed -$410K
65 66
67
68 69

Similar funds

MAM
Magellan Asset Management Sydney, Australia $7.71B AUM 11.08% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
WRCM
Whale Rock Capital Management Boston, Massachusetts $7.74B AUM 180.85% 1-Year Est. Return
IMCOOI
Investment Management Corp of Ontario (IMCO) Toronto, Canada $7.76B AUM 99.29% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $7.77B AUM 9.43% 1-Year Est. Return
CCM
Carronade Capital Management Darien, Connecticut $7.65B AUM 80.26% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
PGFC
Peapack-Gladstone Financial Corp Bedminster, New Jersey $7.82B AUM 21.06% 1-Year Est. Return

Boothbay Fund Management's Q2 2023 Portfolio in Review

As of Q2 2023, Boothbay Fund Management held 2,634 positions worth $4.56B, down 6.5% from $4.87B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Boothbay Fund Management withdrew a net $742M in Q2 2023, closing 900 positions and reducing 471 holdings. Its most notable exit was Alternus Clean Energy Inc, an estimated $12.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 10% of assets, down from 10% a quarter earlier, followed by Technology and Financials.

Against the trend, Boothbay Fund Management opened a new position in Indivior Pharmaceuticals worth $21.9M.

  • Boothbay Fund Management's largest Q2 2023 buy was Indivior Pharmaceuticals: 946,208 shares worth $21.9M.
  • Boothbay Fund Management added most to State Street SPDR S&P 500 ETF Trust in Q2 2023, an estimated $26.9M increase.
  • Boothbay Fund Management's biggest Q2 2023 reduction was Churchill Capital Corp VII Class A Common Stock, cutting an estimated $23.1M.
  • Boothbay Fund Management fully exited Alternus Clean Energy Inc in Q2 2023, selling an estimated $12.1M.
  • Boothbay Fund Management's ten largest holdings make up 15% of its $4.56B portfolio in Q2 2023.
  • Boothbay Fund Management opened 531 new positions and closed 900 in Q2 2023.
  • Boothbay Fund Management's portfolio value fell 6.5% quarter-over-quarter to $4.56B.

Based on Boothbay Fund Management's 13F filing for Q2 2023, filed 14 Aug 2023.